A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP2205 in Healthy Young Males and Females and Elderly Females and to Evaluate the Effect of Food on the Pharmacokinetics of a Single Dose of of ASP2205

Clinical trial NCT02314793 · TERMINATED

Trial details

NCT number: NCT02314793
Sponsor: Astellas Pharma Europe B.V.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Pharmacokinetics of ASP2205

Start date: 2014-11-01
Primary completion: 2015-10-01
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.